53 related articles for article (PubMed ID: 35000669)
1. PKM2 promotes glioma progression by mediating CTNNB1 expression.
Ma C; Feng Y; Zhong K; Wei J
Neurol Res; 2024 Jul; 46(7):583-592. PubMed ID: 38797679
[TBL] [Abstract][Full Text] [Related]
2. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
[TBL] [Abstract][Full Text] [Related]
3. PKM2, cancer metabolism, and the road ahead.
Dayton TL; Jacks T; Vander Heiden MG
EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
[TBL] [Abstract][Full Text] [Related]
4. Translocalization of enhanced PKM2 protein into the nucleus induced by cancer upregulated gene 2 confers cancer stem cell-like phenotypes.
Yawut N; Kaowinn S; Cho IR; Budluang P; Kim S; Kim S; Youn SE; Koh SS; Chung YH
BMB Rep; 2022 Feb; 55(2):98-103. PubMed ID: 35000669
[TBL] [Abstract][Full Text] [Related]
5. CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin.
Kaowinn S; Oh S; Moon J; Yoo AY; Kang HY; Lee MR; Kim JE; Hwang DY; Youn SE; Koh SS; Chung YH
Int J Oncol; 2019 Apr; 54(4):1295-1305. PubMed ID: 30968157
[TBL] [Abstract][Full Text] [Related]
6. Elevated Expression of JMJD5 Protein Due to Decreased miR-3656 Levels Contributes to Cancer Stem Cell-Like Phenotypes under Overexpression of Cancer Upregulated Gene 2.
Yawut N; Cho IR; Budluang P; Kaowinn S; Kaewpiboon C; Jeon B; Kim SW; Kang HY; Kang MK; Koh SS; Chung YH
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053270
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Cancer Upregulated Gene 2 (CUG2) Decreases Spry2 Through c-Cbl, Leading to Activation of EGFR and β-Catenin Signaling.
Yawut N; Kaewpiboon C; Budluang P; Cho IR; Kaowinn S; Koh SS; Chung YH
Cancer Manag Res; 2020; 12():10243-10250. PubMed ID: 33116878
[TBL] [Abstract][Full Text] [Related]
8. Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway.
Wang C; Zhang S; Liu J; Tian Y; Ma B; Xu S; Fu Y; Luo Y
Cell Rep; 2020 Feb; 30(6):1780-1797.e6. PubMed ID: 32049010
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway.
Xu Q; Wu N; Li X; Guo C; Li C; Jiang B; Wang H; Shi D
Cell Death Dis; 2019 Nov; 10(12):874. PubMed ID: 31745071
[TBL] [Abstract][Full Text] [Related]
10. Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axis.
Kaowinn S; Seo EJ; Heo W; Bae JH; Park EJ; Lee S; Kim YJ; Koh SS; Jang IH; Shin DH; Chung YH
Biochem Biophys Res Commun; 2019 Jul; 514(4):1278-1284. PubMed ID: 31113615
[TBL] [Abstract][Full Text] [Related]
11. Cancer upregulated gene (CUG)2 elevates YAP1 expression, leading to enhancement of epithelial-mesenchymal transition in human lung cancer cells.
Kaowinn S; Yawut N; Koh SS; Chung YH
Biochem Biophys Res Commun; 2019 Mar; 511(1):122-128. PubMed ID: 30771899
[TBL] [Abstract][Full Text] [Related]
12. STAT1‑HDAC4 signaling induces epithelial‑mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2.
Kaowinn S; Kaewpiboon C; Koh SS; Krämer OH; Chung YH
Oncol Rep; 2018 Nov; 40(5):2619-2627. PubMed ID: 30226605
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
